FDA Approval Activities for this Drug…

Betaxon (levobetaxolol hydrochloride ophthalmic suspension),0.5%, Alcon Universal,Limited NDA 21-114 2/29/00 Betaxon Indication: for lowering intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension. Dosage form/route of administration is new

For the latest approval information, please locate this drug using this index.